08:00 , Nov 18, 2013 |  BC Week In Review  |  Clinical News

Aptima HPV 16 18/45 Genotype Assay regulatory update

Hologic said FDA approved the Aptima HPV 16 18/45 Genotype Assay for use on Hologic's fully automated Panther system to detect the presence of HPV genotypes 16, 18 and/or 45 infection. The assay is indicated...
07:00 , Jul 29, 2013 |  BC Week In Review  |  Clinical News

Aptima HPV assay regulatory update

Hologic said FDA approved the Aptima HPV assay for use on Hologic's fully-automated Panther system to detect 14 high-risk strains of HPV associated with cervical cancer and precancerous lesions. Specifically, the Aptima HPV assay is...
07:00 , Jun 17, 2013 |  BC Week In Review  |  Company News

Hologic, Quest Diagnostics sales and marketing update

The partners entered a five-year, non-exclusive deal to allow Quest to offer a broader range of Hologic's Aptima diagnostic products and to co-develop and promote diagnostics to improve women's health. Hologic's Aptima products include FDA-approved...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Clinical News

Aptima HPV Assay regulatory update

Hologic said Health Canada approved Aptima HPV Assay to detect 14 high-risk HPV types associated with cervical cancer and precancerous lesions and Aptima HPV 16 18/45 Genotype Assay to assess the presence or absence of...
07:00 , Oct 22, 2012 |  BC Week In Review  |  Clinical News

Aptima HPV 16 18/45 Genotype Assay regulatory update

Hologic said that FDA approved Aptima HPV 16 18/45 Genotype Assay for use on its Tigris instrument system to detect HPV genotypes 16, 18 and/or 45 in specimens that tested positive on Hologic's Aptima HPV...
00:06 , Mar 16, 2012 |  BC Extra  |  Company News

HPV testing included in cervical cancer screening guidelines

The U.S. Preventive Services Task Force (USPSTF) released a final version of cervical cancer screening guidelines that recommends HPV screening as an option for women ages 30-65 in combination with cytology testing. The final version...
08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Small-fry squashed

Among last year's best-performing large cap biotechs were an acquiree and an acquirer: HCV play Pharmasset Inc. and Valeant Pharmaceuticals International Inc. Other big cap stocks also did well overall, while investors abandoned their small-...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Clinical News

Aptima HPV assay regulatory update

FDA approved a PMA from Gen-Probe for its Aptima HPV assay to detect 14 high-risk HPV types associated with cervical cancer and precancerous lesions. The test is indicated to screen women >=21 years whose Pap...
01:17 , Nov 1, 2011 |  BC Extra  |  Company News

FDA approves Gen-Probe's HPV assay

FDA approved a PMA from Gen-Probe Inc. (NASDAQ:GPRO) for its Aptima HPV assay to detect 14 high-risk HPV types associated with cervical cancer and precancerous lesions. The test is indicated to screen women 21 years...
08:00 , Dec 6, 2010 |  BC Week In Review  |  Clinical News

Aptima HPV assay regulatory update

Gen-Probe submitted a PMA to FDA for its Aptima HPV assay to detect E6 and E7 mRNA associated with progression of HPV infection to cervical cancer. The amplified nucleic acid test is designed for use...